Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RAtrium Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Atrium Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $3M. Net result −$20.19M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $3M. Running result $3M. Revenue: $3M.
  • Cost of revenue: $0. Running result $3M.
  • Gross profit: $3M. Running result $3M.
  • Research and development: −$15.34M. Running result −$12.34M.
  • General and administrative: −$10.28M. Running result −$22.62M.
  • Operating income: −$22.62M. Running result −$22.62M.
  • Other income: $2.43M. Running result −$20.19M.
  • Pre-tax loss: −$20.19M. Running result −$20.19M.
  • Income tax benefit: $0. Running result −$20.19M.
  • Net loss: −$20.19M. Running result −$20.19M.